Hcn1em2Cecad
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Hcn1em2Cecad |
| Name: |
hyperpolarization activated cyclic nucleotide gated potassium channel 1; endonuclease-mediated mutation 2, CECAD, University of Cologne |
| MGI ID: |
MGI:7378664 |
| Synonyms: |
Hcn1em2(M142I)Cecad, Hcn1M142I, Hcn1MI |
| Gene: |
Hcn1 Location: Chr13:117738856-118117564 bp, + strand Genetic Position: Chr13, 66.34 cM
|
| Alliance: |
Hcn1em2Cecad page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: CRISPR/Cas9 technology generated a methionine to isoleucine substitution at amino acid 142 (p.M142I). The p.M142I mutation is orthologous to the human pathogenic variant p.M153I seen in developmental and epileptic encephalopathy.
(J:330406)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Hcn1 Mutation: |
51 strains or lines available
|
|
| Original: |
J:330406 Merseburg A, et al., Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy. Elife. 2022 Aug 16;11:e70826 |
| All: |
1 reference(s) |
|